Remdesivir Gets FDA Approval As First COVID-19 Treatment
After clinical trials showed the safety and efficacy of Veklury (remdesivir) in adult and pediatric patients 12 years of age and older, the U.S. Food and Drug Administration has approved the antiviral drug for the treatment of severe COVID-19 - requiring hospitalization.
Veklury is the first treatment for COVID-19 to receive such FDA approval but it did get an Emergency Use Authorization (EUA) on May 1, 2020.
The approval of Veklury was supported by the agency’s analysis of data from three randomized, controlled clinical trials that included patients hospitalized with mild-to-severe COVID-19…